References

Pre-eclampsia and the hypertensive disorders of pregnancy

10.1093/bmb/ldg005 · 2003 · External reference

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002

2002 · External reference

Preeclampsia: an excessive maternal inflammatory response to pregnancy

10.1016/s0002-9378(99)70239-5 · 1999 · External reference

Latest advances in understanding preeclampsia

10.1126/science.1111726 · 2005 · External reference

Preeclampsia – more than pregnancy-induced hypertension

10.1016/0140-6736(93)90889-o · 1993 · External reference

Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy

10.1016/j.placenta.2009.02.009 · 2009 · External reference

Unresolved reference

External reference

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

10.1136/bmj.38380.674340.e0 · 2005 · External reference

Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal

10.1080/00016340903008953 · 2009 · External reference

Unresolved reference

1991 · External reference

Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A

10.1016/s0014-5793(01)02760-0 · 2001 · External reference

Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation

10.1210/jcem.87.5.8448 · 2002 · External reference

Plasma concentrations of four pregnancy proteins in complications of pregnancy

10.1016/0002-9378(77)90725-6 · 1977 · External reference

Concentration of pregnancy-associated plasma protein A (PAPP-A) in patients with pre-eclamptic toxaemia

1981 · External reference

Assay of a placental protein to determine fetal risk

10.1136/bmj.280.6215.671 · 1980 · External reference

Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin

10.1081/prg-120016794 · 2003 · External reference

Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome

10.1002/pd.407 · 2002 · External reference

First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications

10.1111/j.1471-0528.2000.tb11618.x · 2000 · External reference

Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth

10.1210/jcem.87.4.8430 · 2002 · External reference

Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies

10.1111/j.1600-0412.2004.00277.x · 2004 · External reference

Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler

10.1002/pd.1251 · 2005 · External reference

Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia

10.1002/pd.1890 · 2008 · External reference

First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)

10.1016/j.ajog.2004.06.052 · 2004 · External reference

Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks’ gestation

10.1002/uog.3881 · 2007 · External reference

First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia

10.1002/uog.6280 · 2009 · External reference

First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia

10.1002/uog.3876 · 2007 · External reference

First-trimester prediction of hypertensive disorders in pregnancy

10.1161/hypertensionaha.108.127977 · 2009 · External reference

Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes

10.1002/pd.2116 · 2008 · External reference

First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia

10.1002/pd.2339 · 2009 · External reference

Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A

10.1016/j.fertnstert.2007.02.024 · 2008 · External reference

Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells

10.1073/pnas.86.13.5114 · 1989 · External reference

Endocrine control of inhibin biosynthesis by human placenta

1985 · External reference

Serum markers for predicting pre-eclampsia

10.1016/j.mam.2007.04.002 · 2007 · External reference

Induced expression of the new cytokine, activin A, in human monocytes: inhibition by glucocorticoids and retinoic acid

10.1046/j.1365-2567.1996.d01-675.x · 1996 · External reference

Activin A and inhibin A as possible endocrine markers for pre-eclampsia

10.1016/s0140-6736(96)09264-1 · 1997 · External reference

Hypertension in pregnancy: changes in activin A maternal serum concentration

10.1016/0143-4004(95)90102-7 · 1995 · External reference

Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin

10.1111/j.1600-0897.1998.tb00386.x · 1998 · External reference

Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia

10.1002/pd.1606 · 2006 · External reference

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia

10.1371/journal.pone.0004453 · 2009 · External reference

Adhesion molecules, activin and inhibin—candidates for the biochemical prediction of hypertensive diseases in pregnancy?

10.1007/s00404-003-0514-9 · 2004 · External reference

Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies

10.1016/s0002-9378(99)70606-x · 1999 · External reference

Placental production and maternal serum and urine levels of inhibin A and activin A are modified by antihypertensive therapy in hypertensive disorders of pregnancy

10.1111/j.1365-2265.2008.03426.x · 2009 · External reference

Maternal serum inhibin A can predict pre-eclampsia

10.1111/j.1471-0528.1998.tb09943.x · 1998 · External reference

Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia

10.1016/s0002-9378(99)70448-5 · 1999 · External reference

Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7–13weeks into pregnancy

10.1016/s0002-9378(03)00902-5 · 2003 · External reference

First trimester inhibin-A concentrations and later development of preeclampsia

2004 · External reference

Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia

10.1093/humrep/15.7.1640 · 2000 · External reference

Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?

10.1016/j.ajog.2008.06.071 · 2008 · External reference

Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22+0 to 24+6 weeks’ gestation

10.1002/uog.2676 · 2006 · External reference

First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels

10.1159/000094672 · 2007 · External reference

Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia

2003 · External reference

Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?

10.1034/j.1600-0412.2002.810611.x · 2002 · External reference

Functional analyses of placental protein 13/galectin-13

10.1111/j.1432-1033.2004.04004.x · 2004 · External reference

Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies

10.1016/j.placenta.2003.12.009 · 2004 · External reference

Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome

10.1007/s00428-008-0658-x · 2008 · External reference

A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound

10.1002/uog.2686 · 2006 · External reference

First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction

10.1016/j.ajog.2007.02.025 · 2007 · External reference

Longitudinal determination of serum placental protein 13 during development of preeclampsia

10.1159/000151344 · 2008 · External reference

First-trimester maternal serum PP13 in the risk assessment for preeclampsia

10.1016/j.ajog.2008.01.013 · 2008 · External reference

Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study

10.1111/j.1471-0528.2008.01902.x · 2008 · External reference

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk

10.1002/pd.2287 · 2009 · External reference

Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia

10.1002/pd.1664 · 2007 · External reference

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

10.1172/jci17189 · 2003 · External reference

Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria

10.1074/jbc.c300012200 · 2003 · External reference

Soluble endoglin contributes to the pathogenesis of preeclampsia

10.1038/nm1429 · 2006 · External reference

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia

10.1056/nejmoa055352 · 2006 · External reference

Preeclampsia is associated with reduced serum levels of placenta growth factor

10.1016/s0002-9378(98)70021-3 · 1998 · External reference

Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia

10.1111/j.1471-0528.1999.tb08107.x · 1999 · External reference

Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia

10.1067/mob.2000.108022 · 2000 · External reference

Circulating angiogenic factors and the risk of preeclampsia

10.1056/nejmoa031884 · 2004 · External reference

Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia

10.1016/j.ejogrb.2004.11.015 · 2005 · External reference

Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor

10.1210/jc.2004-1955 · 2005 · External reference

Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia

10.1016/j.ajog.2005.12.049 · 2006 · External reference

Urinary podocyte excretion as a marker for preeclampsia

10.1016/j.ajog.2007.02.007 · 2007 · External reference

Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension

10.1080/10641950701825937 · 2008 · External reference

Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia

10.1210/jc.2002-021942 · 2003 · External reference

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences

10.1210/jc.2003-030528 · 2003 · External reference

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award

10.1016/j.ajog.2004.03.043 · 2004 · External reference

Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop

10.1016/j.ajog.2004.03.004 · 2004 · External reference

Plasma markers of angiogenesis in pregnancy induced hypertension

10.1160/th05-03-0167 · 2005 · External reference

Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia

10.1159/000101483 · 2007 · External reference

Maternal Serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia

10.1373/clinchem.2004.036715 · 2004 · External reference

Soluble fms-like tyrosine kinase 1

10.1056/nejm200411183512123 · 2004 · External reference

Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia

10.1016/j.ajog.2007.03.036 · 2007 · External reference

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

10.1067/mob.2003.111 · 2003 · External reference

Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia

10.1111/j.1471-0528.1997.tb11050.x · 1997 · External reference

Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia

10.1016/j.ijgo.2004.10.005 · 2005 · External reference

Angiogenic factors and preeclampsia

10.2741/2241 · 2007 · External reference

Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia

10.1016/s0029-7844(03)00338-7 · 2003 · External reference

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

10.1067/mob.2001.113129 · 2001 · External reference

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia

10.1210/jc.2003-031244 · 2004 · External reference

Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia

10.1016/j.ajog.2006.10.909 · 2007 · External reference

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age

10.1080/14767050802034545 · 2008 · External reference

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

10.3109/14767050902994754 · 2009 · External reference

First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction

10.1016/s0029-7844(01)01528-9 · 2001 · External reference

Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth

10.1097/01.aog.0000265804.09161.0d · 2007 · External reference

Plasma placenta growth factor levels in midtrimester pregnancies

10.1016/s0029-7844(01)01497-1 · 2001 · External reference

Decreased maternal serum placenta growth factor in early second trimester and preeclampsia

10.1016/s0029-7844(01)01341-2 · 2001 · External reference

A longitudinal study of biochemical variables in women at risk of preeclampsia

10.1067/mob.2002.122969 · 2002 · External reference

Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia

10.1081/prg-120028286 · 2004 · External reference

Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia

10.3346/jkms.2007.22.5.873 · 2007 · External reference

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

10.1016/j.ajog.2006.11.002 · 2007 · External reference

Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia

10.1016/j.ajog.2007.05.022 · 2007 · External reference

10.1080/14767050701830480

10.1080/14767050701830480 · 2008 · External reference

Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia

10.1002/uog.6244 · 2008 · External reference

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction

10.1002/uog.5184 · 2008 · External reference

Placental growth factor: a predictive marker for preeclampsia?

10.1159/000197908 · 2009 · External reference

Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia

10.1002/pd.998 · 2004 · External reference

Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation

10.1002/pd.2143 · 2008 · External reference

Angiogenic factors for the prediction of preeclampsia in high-risk women

10.1016/j.ajog.2007.06.030 · 2007 · External reference

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion

10.1016/j.ajog.2007.08.052 · 2008 · External reference

Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion

10.1161/01.hyp.0000258404.21552.a3 · 2007 · External reference

Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry

10.1016/j.ijgo.2008.02.016 · 2008 · External reference

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia

10.1161/hypertensionaha.107.087700 · 2007 · External reference

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors

10.1097/aog.0b013e3181719b7a · 2008 · External reference

Circulating angiogenic factors and placental abruption

10.1097/01.aog.0000216014.72503.09 · 2006 · External reference

Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia

10.1038/ajh.2009.97 · 2009 · External reference

Disturbed feto-maternal cell traffic in preeclampsia

10.1016/s0029-7844(98)00068-4 · 1998 · External reference

Elevation in erythroblast count in maternal blood before the onset of preeclampsia

10.1067/mob.2001.108861 · 2001 · External reference

Increased fetal erythroblasts in women who subsequently develop pre-eclampsia

10.1093/humrep/15.7.1624 · 2000 · External reference

Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia

10.1093/clinchem/45.2.184 · 1999 · External reference

Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia

10.1093/clinchem/47.1.137 · 2001 · External reference

Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia

10.1111/j.1749-6632.2001.tb03874.x · 2001 · External reference

The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia

10.1081/prg-120002911 · 2002 · External reference

Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia

10.1016/j.ajog.2003.12.019 · 2004 · External reference

A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma

10.1007/978-1-59745-066-9_22 · 2008 · External reference

Value of HCG and HCS measurement in clinical practice

1974 · External reference

Maternal serum human chorionic gonadotropin level at 15 weeks is a predictor for preeclampsia

10.1016/s0002-9378(96)70247-8 · 1996 · External reference

Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry

10.1159/000081369 · 2005 · External reference

Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia

10.1002/1097-0223(200009)20:9<738::aid-pd917>3.0.co;2-r · 2000 · External reference

The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia

10.1016/s0002-9378(97)70512-x · 1997 · External reference

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

10.1016/s0140-6736(03)13177-7 · 2003 · External reference

Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia

10.1016/s0002-9378(98)70437-5 · 1998 · External reference

Asymmetric dimethylarginine (ADMA) in the maternal and fetal circulation in preeclampsia

10.1203/pdr.0b013e3181b33392 · 2009 · External reference

Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia

10.1080/j.1600-0412.1998.770805.x · 1998 · External reference

Reduced l-arginine level and decreased placental eNOS activity in preeclampsia

10.1016/j.placenta.2005.04.011 · 2006 · External reference

Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia

10.1001/jama.291.7.823 · 2004 · External reference

Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants

10.1016/j.ajog.2007.05.052 · 2008 · External reference

High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension

1996 · External reference

Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies

10.1111/j.1471-0528.1995.tb09063.x · 1995 · External reference

The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia

10.1210/jc.2004-0186 · 2004 · External reference

The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia

10.1002/uog.29 · 2003 · External reference

AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia

10.1007/s00109-008-0332-4 · 2008 · External reference

Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

10.1038/nm.1856 · 2008 · External reference

Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus

10.1161/hypertensionaha.109.130583 · 2009 · External reference

A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia

10.1111/j.1471-0528.2009.02283.x · 2009 · External reference

Detection and identification of novel metabolomic biomarkers in preeclampsia

10.1177/1933719108316908 · 2008 · External reference

First trimester urinary placental growth factor and development of pre-eclampsia

10.1111/j.1471-0528.2008.02074.x · 2009 · External reference

Urinary placental growth factor and risk of preeclampsia

10.1001/jama.293.1.77 · 2005 · External reference

Low urinary placental growth factor is a marker of pre-eclampsia

10.1038/sj.ki.5000075 · 2006 · External reference

Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia

10.1016/j.ajog.2004.12.052 · 2005 · External reference

Metabolic syndrome in early pregnancy and risk of preterm birth

10.1093/aje/kwp211 · 2009 · External reference

Association between maternal seafood consumption before pregnancy and fetal growth: evidence for an association in overweight women. The EDEN mother–child cohort

10.1111/j.1365-3016.2008.00982.x · 2009 · External reference

Patterns of change in uterine artery Doppler studies between 20 and 24 weeks of gestation and pregnancy outcomes

10.1097/aog.0b013e318195b223 · 2009 · External reference

Growth, development and health from early fetal life until young adulthood: the Generation R Study

10.1111/j.1365-3016.2003.00521.x · 2004 · External reference

The Danish National Birth Cohort—its background, structure and aim

10.1177/14034948010290040201 · 2001 · External reference

The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years

10.1007/s10654-006-9041-x · 2006 · External reference

Nordic biological specimen banks as basis for studies of cancer causes and control—more than 2 million sample donors, 25 million person years and 100,000 prospective cancers

10.1080/02841860701203545 · 2007 · External reference

The longitudinal study of the northern Finland birth cohort of 1966

10.1111/j.1365-3016.1988.tb00180.x · 1988 · External reference

Insulin-like growth factor I in pregnancy and maternal risk of breast cancer

10.1158/1055-9965.epi-06-0625 · 2006 · External reference

Child health and the environment: the INMA Spanish Study

10.1111/j.1365-3016.2006.00745.x · 2006 · External reference

Children of the nineties. A longitudinal study of pregnancy and childhood based on the population of Avon (ALSPAC)

1990 · External reference

10.1086/431245

10.1086/431245 · External reference

Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction study

10.1186/1471-2393-8-51 · 2008 · External reference

Maternal vitamin D intake during pregnancy and early childhood wheezing

10.1093/ajcn/85.3.853 · 2007 · External reference

Obesity and preeclampsia: the potential role of inflammation

10.1016/s0029-7844(01)01551-4 · 2001 · External reference

Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods

10.1016/s0197-2456(96)00106-7 · 1996 · External reference